Education
About Us
Working with TipRanks
Follow Us
Eloxx Pharmaceuticals Inc (ELOX)
OTHER OTC:ELOX
ELOX Stock Chart & Stats
$0.75
$0.00(0.00%)
At close: 4:00 PM EST
$0.75
$0.00(0.00%)
Day’s Range― - ―
52-Week Range$0.02 - $0.75
Previous CloseN/A
Volume500.00
Average Volume (3M)32.00
Market Cap
$330.00
Enterprise ValueN/A
Total Cash (Recent Filing)$4.78M
Total Debt (Recent Filing)$5.76M
Price to Earnings (P/E)―
Beta-1692.94
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-9.06
Shares Outstanding3,300,528
10 Day Avg. Volume32
30 Day Avg. Volume32
Financial Highlights & Ratios
PEG Ratio<0.01
Price to Book (P/B)-0.37
Price to Sales (P/S)0.00
P/FCF Ratio-0.12
Enterprise Value/Market Cap0.00
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/Ebitda0.00
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)-6.65
Revenue Forecast (FY)N/A
Eloxx Pharmaceuticals News
ELOX FAQ
What was Eloxx Pharmaceuticals Inc’s price range in the past 12 months?
Eloxx Pharmaceuticals Inc lowest stock price was $0.02 and its highest was $0.75 in the past 12 months.
What is Eloxx Pharmaceuticals Inc’s market cap?
Eloxx Pharmaceuticals Inc’s market cap is $330.00.
When is Eloxx Pharmaceuticals Inc’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Eloxx Pharmaceuticals Inc’s earnings last quarter?
Currently, no data Available
Is Eloxx Pharmaceuticals Inc overvalued?
According to Wall Street analysts Eloxx Pharmaceuticals Inc’s price is currently Overvalued.
Does Eloxx Pharmaceuticals Inc pay dividends?
Eloxx Pharmaceuticals Inc does not currently pay dividends.
What is Eloxx Pharmaceuticals Inc’s EPS estimate?
Eloxx Pharmaceuticals Inc’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Eloxx Pharmaceuticals Inc have?
Eloxx Pharmaceuticals Inc has 3,300,528 shares outstanding.
What happened to Eloxx Pharmaceuticals Inc’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Eloxx Pharmaceuticals Inc?
Currently, no hedge funds are holding shares in ELOX
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Eloxx Pharmaceuticals Inc
Eloxx Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on developing ribosome modulation for the treatment of rare and ultra-rare premature stop codon diseases. Its lead investigational drug product candidate is ELX-02, which is in Phase 2 clinical trial for the treatment of cystic fibrosis and nephropathic cystinosis patients with diagnosed nonsense mutations. The company also develops various preclinical programs for the treatment of alport syndrome, recessive dystrophic epidermolysis bullosa, junctional epidermolysis bullosa, and familial adenomatous polyposis, as well as various earlier discovery stage programs in oncology. Eloxx Pharmaceuticals, Inc. was founded in 2013 and is headquartered in Watertown, Massachusetts.
AIM ImmunoTech
―
Biodexa Pharmaceuticals
―
Salarius Pharmaceuticals
―
Dermata Therapeutics
―
Virax Biolabs Group Ltd. Class A
―
Ownership Overview
7.52% Insiders
<0.01% Other Institutional Investors
92.48% Public Companies and
Individual Investors
Options Prices
Currently, No data available
---